Skip to main content

About CRUK Scotland Institute

Find out what we do, how we do it and why we do what we do.

A person walks across a city street at sunset, with tall buildings lining the road on both sides.

Life in Glasgow

Find out about living and working in Glasgow and Scotland.

Our Research

Explore the science at CRUK Scotland Institute. Our research groups, the people who lead them, and how we work.

Operations

The teams and services that keep the Institute running and support our research.

Partners

The networks and organisations we work with to accelerate cancer research.

Careers & Study

Jobs, studentships and opportunities for students at every stage at our world-renowned cancer research institute.

Studentships

PhD opportunities at the Institute

Studentship Vacancies

Open studentships to apply for

Internships

For undergraduate and masters students

Molecular Imaging

Group Leader:
Prof David Lewis

Our lab focuses on understanding cancer as a metabolic disease, using molecular and total-body PET imaging to map how tumours use, compete for, and rewire nutrients across scales. We combine advanced cancer models, novel radiotracers, and quantitative image analysis to characterise metabolic phenotypes from single cells and tumour subregions through to whole-body physiology. By linking imaging signatures to genetics, microenvironmental context, and treatment response, we aim to uncover metabolic vulnerabilities that can be targeted to improve outcomes for patients.

A central theme of our work is the metabolic interplay between tumours and the host. We investigate how tumours reprogram their metabolism under therapeutic pressure, how distinct metabolic states contribute to drug and radiotherapy resistance, and how systemic conditions such as cancer cachexia develop. Through total-body PET, we visualise these processes in vivo. Our programs span mechanistic studies in GEMMs and organoids, development of novel PET tracers, and translational imaging trials across radiotherapy and systemic therapies.

A blue pencil icon tilted diagonally, drawing a horizontal line on a plain light grey background.

Lab Reports

click here to read
Blue icon of a document with horizontal lines representing text and a folded bottom right corner, on a light grey background.

Recent Publications

click here to read
A pink icon of three people on a light grey background, with one person in front and two slightly behind on either side, representing a group or community.

Lab Members

click here to read

Recent Publications

2026

Raffo-Iraolagoitia, X.L., Alyamani, A., May, S. et al. Multiscale in vivo imaging of tumor evolution using a germline conditional triple-reporter mouse. Nat Biotechnol (2026).

Maria Francesca Allega et al. ,Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma.Sci. Adv.12,eadx6539(2026).

Williams, H.L., Poulain, N., Powley, I. et al. Spatial Molecular Plasticity Underpins Lethal Morphologies in Lung Adenocarcinoma. Modern Pathology 39, 03 (2026). 

2025

Shaw, R.C., Morgan, T.E.F., McErlain, H. et al. Assessment of a 6-arylaminobenzamide lead derivative as a potential core scaffold for S1P5 positron emission tomography radiotracer development. Bioorg Med Chem119, 118057 (2025).

Müller, M., May, S., Hall, H., Kendall, T. J., McGarry, L., Blukacz, L., Nuciforo, S., Georgakopoulou, A., Jamieson, T., Phinichkusolchit, N. (2025). Human-correlated genetic models identify precision therapy for liver cancer. Nature.

Sushentsev, N., Hamm, G., Manavaki, R., McLean, M. A., Birchall, J., Soloviev, D., Lewis, D. Y., Aloj, L., Flint, L., Zakirov, A.(2025). Spatial metabolomics informs the use of clinical imaging for improved detection of cribriform prostate cancer. Proceedings of the National Academy of Sciences.122 (26), e2502423122.

2024

Malviya, G., Lannagan, T. R. M., Johnson, E., Mackintosh, A., Bielik, R., Peters, A., Soloviev, D., Brown, G., Jackstadt, R., Nixon, C. (2024). Noninvasive stratification of colon cancer by multiplex PET imaging. Clinical Cancer Research. 30 (8), 1518-1529.

2023

Dzien, P., Mackintosh, A., Malviya, G., Johnson, E., Soloviev, D., Brown, G., Uribe, A. H., Nixon, C., Lyons, S. K., Maddocks, O. (2023). Positron emission tomography imaging of the sodium iodide symporter senses real-time energy stress in vivo. Cancer & Metabolism. 11 (1), 14.

Ferrer, M., Anthony, T. G., Ayres, J. S., Biffi, G., Brown, J. C., Caan, Bette J; Feliciano, E. M. C., Coll, A. P., Dunne, R. F., Goncalves, M. D. (2023). Cachexia: A systemic consequence of progressive, unresolved disease. Cell. 186 (9),1824-1845.

2021

Najumudeen, A. K., Ceteci, F., Fey, S. K., Hamm, G., Steven, R. T., Hall, H., Nikula, C. J., Dexter, A., Murta, T., Race, A. M. (2021). The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer. Nature Genetics. 53 (1), 16-26.

2018

Lewis, D. Y., Mair, R., Wright, A., Allinson, K., Lyons, S. K., Booth, T., Jones, J., Bielik, R., Soloviev, D., Brindle, K. M. (2018) [18F] fluoroethyltyrosine-induced Cerenkov Luminescence Improves Image-Guided Surgical Resection of Glioma.Theranostics.8 (14), 3991.

2015

Lewis, D. Y., Soloviev, D., Brindle, K. M. (2015). Imaging tumor metabolism using positron emission tomography. Cancer Journal (Sudbury, Mass.). 21 (2), 129-136.

2014

Lewis, D. Y., Boren, J., Shaw, G. L., Bielik, R., Ramos-Montoya, A., Larkin, T. J., Martins, C. P., Neal, D. E., Soloviev, D., Brindle, K. M. (2014). Late imaging with [1-11C] acetate improves detection of tumor fatty acid synthesis with PET. Journal of Nuclear Medicine. 55 (7), 1144-1149.

Group Leader

A man with short light brown hair and a trimmed beard, wearing a white collared shirt, poses against a plain light grey background, softly smiling at the camera.

Lab Members

Principal Scientific Officer

A person with shoulder-length brown hair, wearing a dark blazer over a light collared shirt, smiles whilst standing outdoors in front of a blurred background with green foliage and glass windows.

Emma Brown

As part of my role in the lab, I ensure the efficient running of the Translational Molecular Imaging facility and engage in multiple collaborative projects within the CRUK SI and further afield. My research interests surround the use of molecular imaging to non-invasively probe tumour evolution, and the biological validation of in vivo imaging signals. As part of Team CANCAN, a Cancer Cachexia Cancer Grand Challenge, I apply broad knowledge of molecular imaging and mouse models to use pre-clinical PET/MRI to probe systemic changes in metabolism during tumour development and cancer cachexia.

Email me

Translational GMP Radiochemist

A young woman with long blonde hair and glasses stands outdoors, wearing a white shirt and smiling. A blurred background shows trees and a stone wall.

Valeria Burianova

I am a synthetic organic chemist trained in radiochemistry during my PhD, with expertise in synthesizing novel and established PET tracers. In my current role, I support the development and documentation of PET tracers for clinical research. My work spans early-stage tracer development and validation, GMP protocol design, and quality control/assurance to ensure regulatory compliance. In addition to these responsibilities, I contribute to the production of 11C- and 18F-labeled PET tracers for preclinical applications.

Email me

Research Radiochemist

A man with short dark hair smiles at the camera against a plain light background. He is wearing a dark shirt.

Gavin Brown

As a research radiochemist, I develop radiochemistry methods and techniques to produce radiotracers for application in PET imaging studies. I have experience in using both commercial and custom-built radiochemistry platforms to produce radiotracers for clinical and preclinical PET research in accordance with GMP guidelines and under local quality management systems. Positron-emitting radionuclides used include carbon-11, fluorine-18, zirconium-89, iodine-124, copper-64 and gallium-68.

Email me

Head of Radiochemistry

An older man with grey hair and glasses, wearing a checked shirt, stands outdoors in a mountainous area with green hills and patches of snow in the background.

Dmitry Soloviev

As Head of Radiochemistry, I lead radiochemistry efforts supporting PET imaging studies across Scotland, driving innovation in molecular imaging. My team has extensive expertise in radiopharmaceutical development, short-lived positron-emitting radionuclides, and advanced radiolabelling techniques. We specialize in radiolabelling metabolites to uncover cancer biochemistry and the interplay between disease biology and imaging.

By advancing preclinical and clinical PET studies, we help researchers translate discoveries into real-world impact.

Email me

Senior Preclinical PET Imaging Scientist

A middle-aged man with short brown hair, some grey, and a trimmed beard smiles at the camera. He is wearing a dark jacket over a collared shirt, and the background is plain and light-coloured.

Stephen Paisey

I am a preclinical imaging specialist with 19 years of experience, built upon a background in synthetic inorganic chemistry and radiochemistry. I lead and collaborate on research programmes that apply advanced imaging technologies, including total-body preclinical PET/CT and 7T MRI, to address complex biological questions. As part of my role, I am establishing a radiometal and radiobiology laboratory focused on developing 89Zr radiolabelling methods for biologically derived agents, such as antibodies and cells, enabling the long-term in vivo tracking of emerging biological therapies.

Email me

Principal Scientific Officer

A person with short dark hair is standing outside at night in front of a modern, white building with large windows, looking directly at the camera.

Robert Bielik

I am a PET imaging scientist interested in tumour metabolism. I study the causes and consequences of metabolic heterogeneity in lung cancer and investigate how tumours utilise nutrients such as glucose and acetate across time and multiple scales. I combine multiplexed PET imaging, isotope tracing, omics, mass spectrometry imaging, and spatial biology to uncover metabolic vulnerabilities and guide new therapeutic strategies. In my role, I drive research innovation, provide specialist scientific expertise, support group operations, co-supervise students, and foster internal and external collaborations.

Email me

PET Research Development Manager

A young woman with long brown hair and a black shirt smiles at the camera, against a plain light background.

Una Goncin

I leverage extensive expertise in project management, multimodal imaging, clinical trial management, and communications to drive the growth and impact of PET research in Glasgow. In my role, I lead the development, implementation, and oversight of PET imaging strategy, ensuring operational excellence, resource optimisation, and regulatory My role includes building collaborations, supporting and securing research funding, and creating opportunities for translational success. I lead marketing and outreach initiatives to raise the profile of PET research and ensure its long-term sustainability.

Email me

Senior Scientific Officer

A person with curly dark hair and a nose ring smiling at the camera.

Carol McMenemy

I am a preclinical researcher with expertise in cancer biology and laboratory management. I’m experienced in in vivo cancer modelling, most recently with orthotopic models of PDAC, where I use multiplexed IF to study the TME and TiME. In my current role, I support PET/MRI imaging programmes, integrating molecular imaging, histopathology, and transgenic disease models to understand disease biology, while contributing to the development, operation, and day-to-day management of molecular imaging facilities.

Email me

Secret Link